December 20, 2010 – A magnetic resonance (MR) system with high slew rate gradients and a new user interface is pending 510(k) approval and was announced at the Radiological Society of North America (RSNA) annual meeting. The Vantage Titan HSR 1.5T MR, by Toshiba, is ideal for exams, such as advanced cardiac and neuro imaging, that require higher image quality and faster exams.

The high slew rate gradients (gradient strength 30 [mT/m] | slew rate 203 [mT/m/ms]) improve the capability for advanced cardiac and neuro applications as well as magnetic resonance angiography (MRA) body, breast and abdominal imaging. They also improve temporal and spatial resolution and the ability for clinicians to make accurate diagnoses. The M-Power interface has new efficiency tools as well as advanced post-processing software, enhancing department workflow.

The system also features an open bore that is 18 percent larger than other 1.5T systems on the market and features a large 71 cm patient aperture and outstanding homogeneity. It also has the largest available clinical field-of-view of 55 x 55 x 50 cm.

The system is an enhancement to the Vantage Titan and therefore includes numerous patient-focused features that significantly improve comfort and increase the range of patients who can be imaged. The open bore provides a greater feeling of openness for the patient, and Pianissimo technology dramatically reduces acoustic noise. It also utilizes Atlas Speeder integrated coil technology to reduce exam time. Since the coils are integrated into the table, patients do not need to be continually repositioned. Additionally, many procedures can be performed feet first, reducing claustrophobia.

The system also takes advantage of Toshiba’s contrast-free MRA techniques. Gadolinium, the most common contrast agent used for MRI and MRA exams, has been directly linked to nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). NSF and NFD can be fatal in patients with renal insufficiency

For more information: www.medical.toshiba.com


Related Content

News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now